182 related articles for article (PubMed ID: 16401687)
1. Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
Gut; 2006 Jun; 55(6):824-32. PubMed ID: 16401687
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic action of ghrelin in a mouse model of colitis.
Gonzalez-Rey E; Chorny A; Delgado M
Gastroenterology; 2006 May; 130(6):1707-20. PubMed ID: 16697735
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
[TBL] [Abstract][Full Text] [Related]
5. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
7. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.
Gonzalez-Rey E; Varela N; Sheibanie AF; Chorny A; Ganea D; Delgado M
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4228-33. PubMed ID: 16537513
[TBL] [Abstract][Full Text] [Related]
8. Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response.
Gonzalez-Rey E; Chorny A; Varela N; Robledo G; Delgado M
Am J Pathol; 2006 Jun; 168(6):1921-30. PubMed ID: 16723707
[TBL] [Abstract][Full Text] [Related]
9. Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model.
Kono T; Kaneko A; Hira Y; Suzuki T; Chisato N; Ohtake N; Miura N; Watanabe T
J Crohns Colitis; 2010 Jun; 4(2):161-70. PubMed ID: 21122500
[TBL] [Abstract][Full Text] [Related]
10. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.
Gonzalez-Rey E; Anderson P; González MA; Rico L; Büscher D; Delgado M
Gut; 2009 Jul; 58(7):929-39. PubMed ID: 19136511
[TBL] [Abstract][Full Text] [Related]
11. Oridonin's therapeutic effect: suppressing Th1/Th17 simultaneously in a mouse model of Crohn's disease.
Wang S; Zhang Y; Saas P; Wang H; Xu Y; Chen K; Zhong J; Yuan Y; Wang Y; Sun Y
J Gastroenterol Hepatol; 2015 Mar; 30(3):504-12. PubMed ID: 25211373
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic responses associated with adrenomedullin administration in experimental colitis.
Talero E; Sánchez-Fidalgo S; de la Lastra CA; Illanes M; Calvo JR; Motilva V
Peptides; 2008 Nov; 29(11):2001-12. PubMed ID: 18708104
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
Singer M; Trugnan G; Chelbi-Alix MK
Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
[TBL] [Abstract][Full Text] [Related]
15. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis.
Matsuda C; Ito T; Song J; Mizushima T; Tamagawa H; Kai Y; Hamanaka Y; Inoue M; Nishida T; Matsuda H; Sawa Y
Clin Exp Immunol; 2007 May; 148(2):348-59. PubMed ID: 17437423
[TBL] [Abstract][Full Text] [Related]
17. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of urocortin in lung tissues of rats with allergic asthma.
Wu Y; Zhou H; Xu Y; Li S
Biochem Biophys Res Commun; 2006 Mar; 341(2):532-40. PubMed ID: 16427607
[TBL] [Abstract][Full Text] [Related]
19. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
20. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.
Schmidt N; Gonzalez E; Visekruna A; Kühl AA; Loddenkemper C; Mollenkopf H; Kaufmann SH; Steinhoff U; Joeris T
Gut; 2010 Jul; 59(7):896-906. PubMed ID: 20581238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
